USP32 (ubiquitin specific peptidase 32) by Sapmaz, A & Erson-Bensan, AE
  
 
   
Gene Section 
Short Communication 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 18(1) 46 
INIST-CNRS 
 
OPEN ACCESS JOURNAL 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
USP32 (ubiquitin specific peptidase 32) 
Aysegul Sapmaz, Ayse Elif Erson-Bensan 
Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital (NKI-AVL), Amsterdam, Netherlands (AS), 
Department of Biological Sciences, Middle East Technical University, Ankara, Turkey (AS, AEEB) 
 
Published in Atlas Database: July 2013 
Online updated version : http://AtlasGeneticsOncology.org/Genes/USP32ID52046ch17q23.html 
DOI: 10.4267/2042/52076 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2014 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Abstract: Short communication on USP32, with data on DNA/RNA, on the protein encoded and where the gene is 
implicated. 
 
Identity 
Other names: NY-REN-60, USP10 
HGNC (Hugo): USP32 
Location: 17q23.1 
Local order: Based on Mapviewer (Master Map: Gene 
on sequence, gene flanking USP32 oriented from 
centromere on 17q23.3 are: 
- TBC1D3P1-DHX40P1 (17q23): TBC1D3P1-
DHX40P1 read through transcribed pseudogene 
- MIR4737: MicroRNA 4737 
- HEATR6 (17q23.1): Heat repeat containing 6 
- LOC100422693 (Chr.17): UDP-N-acetyl-alpha-D-
galactosamine :polypeptide N-
acetylgalactosamyltransferase 1 (GalNAc-T1) 
pseudogene 
- LOC6456338 (17q23.1): WDNM1-like pseudogene 
- LOC653653(17q23.1): adaptor-related protein 
complex 1 sigma 2 subunit pseudogene 
- CA4 (17q23): carbonic anhydrase IV 
- FAM106DP (Chr. 17): family with sequence 
similarity 106 memberD pseudogene 
- SCARNA20 (17q23.2): small cajal body specific 
RNA 20 
- RPL32P32 (17q23.2): ribosomal protein L32 
pseudogene 32 
- LOC100418753 (Chr.17): septin 7 pseudogene 
- USP32 (17q23.3): ubiquitin specific protease 32 
- LOC100506882 (Chr.17): uncharacterized 
LOC100506882 
- C17orf64 (17q23.2): chromosome 17 open reading 
frame 64 
- RPL12P38 (17q23.2): ribosomal protein L12 
pseudogene 38 
- HMGN2P42 (Chr.17) high mobility group 
nucleosomal binding domain 2 pseudogen 42 
- APPBP2 (17q23.2): amyloid beta precursor protein 
(cytoplasmic tail binding protein 2. 
 
Figure 1. Genes flanking USP32 gene on 17q23.3. → stands for positive strand , ← stands for negative strand. 
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Figure 2. 34 exons of USP32. 
 
DNA/RNA 
Description 
USP32 gene is located on a prominent gene 
amplification region, 17q23, in breast cancers (Bärlund 
et al., 1997; Erson et al., 2001) and has 34 exons 
(figure 2). 
Transcription 
USP32 mRNA is 7026 bp long. Coding sequence of 
USP32 starts at the 287th bp and ends at the 5101st bp of 
the mRNA. Total length of USP32 coding sequence is 
4815 bp. 
Pseudogene 
No pseudogene has been reported for USP32. 
Protein 
Note 
Three independent studies reported USP32 to be 
phosphorylated at the 1173rd tyrosine and 1372nd serine 
residues (Dephoure et al., 2008; Rigbolt et al., 2011; 
Mayya et al., 2009). 
Description 
USP32 (ubiquitin specific protease 32 - accession 
number: NT_010783 and mRNA accession number: 
NM_032582) encodes for a protein consisting of 1604 
amino acids and the resulting protein's predicted 
molecular weight is approximately 182 kDa. The N-
terminal region contains calcium binding domain with 
EF-hand and DUSP domains. 
The EF-hand calcium binding domains, consisting of a 
helix (E), a loop and a second helix (F) motif, are 
generally found in calcium binding proteins. 
DUSP domain is common among ubiquitin specific 
proteases. The function of this domain in USP32 
remains unclear but is predicted be functional in 
protein-protein interactions. In addition, USP32 harbors 
Cys, His and Asp triad which is common in USP 
subfamily of DUBs (figure 3). Recently, active 
deubiquitination function of USP32 has been 
established (Akhavantabasi et al., 2010). 
Expression 
Overexpressed transcript was detected in malignant 
breast ephitelium (Grigoriadis et al., 2006). Another 
study showed overexpression of USP32 in 50% (9 of 
18) of breast cancer cell lines and 22% (9 of 41) of 
primary breast tumors compared to mammary epithelial 
cells (Akhavantabasi et al., 2010). 
Localisation 
Golgi (Akhavantabasi et al., 2010). 
Function 
USP32 is an active deubiquitinating enzyme 
(Akhavantabasi et al., 2010). 
 
Figure 3. Domains of USP32. 
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Figure 4. Sequence homology between USP32 and USP6. 
 
Homology 
C-terminal of USP32 shows 97% nucleotide homology 
with USP6 (ubiquitin specific protease 6 (Tre-2 
oncogene)) (Paulding et al., 2003) (figure 4). 
Mutations 
Note 
In the Parkinson disease, CNVs in USP32 gene were 
suggested. However, these variations in USP32 were 
not confirmed with Multiplex ligation-dependent probe 
amplification (MLPA) and real time PCR (Pankratz et 
al., 2011). 
Implicated in 
Breast cancer 
Note 
USP32 is located on 17q23 chromosomal region which 
is amplified in breast cancer (Sinclair et al., 2003; 
Haverty et al., 2008). Real-time PCR analysis in breast 
cancer cell lines determined that USP32 transcript is 
amplified more than two-fold in 50% of breast cancer 
cell lines and in 22% of (9 of 41) primary breast tumors 
compared to normal breast tissue samples. Moreover, 
silencing of USP32 leads to a decrease in the 
proliferation and migration properties of HeLa and 
MCF7 cells (Akhavantabasi et al., 2010).  
In estrogen receptor (ER) positive tumors, USP32 may 
have a higher copy number than ER negative tumors 
(Zhang et al., 2009). Scafoglio et al. (2006) suggest 
USP32 to be an estrogen responsive gene. 
Hybrid/Mutated gene 
RT-PCR and transcriptome sequencing analysis 
determined USP32 to be one of the twelve expressed 
fusion genes in breast cancer cell line ZR-75-30. 
USP32 is found to be expressed with CCDC49 as a 
fusion transcript (Schulte et al., 2012). 
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